title: Blood culture contamination: a randomized trial evaluating the comparative effectiveness of 3 skin antiseptic interventions.
abstract: OBJECTIVE
  To determine relative rates of blood culture contamination for 3 skin antisepsis interventions-10% povidone iodine aqueous solution (PI), 2% iodine tincture (IT), and 2% chlorhexidine gluconate in 70% isopropyl alcohol (CHG)-when used by dedicated phlebotomy teams to obtain peripheral blood cultures.
  
  
  METHODS
  Randomized crossover trial with hospital floor as the unit of randomization.
  
  
  METHODS
  Teaching hospital with 885 beds.
  
  
  METHODS
  All adult patients undergoing peripheral blood culture collection on 3 medical-surgical floors from May 2009 through September 2009.
  
  
  METHODS
  Each antisepsis intervention was used for 5 months on each study floor, with random crossover after a 1-month washout period. Phlebotomy teams collected all peripheral blood cultures. Each positive blood culture was adjudicated by physicians blinded to the intervention and scored as a true positive or contaminated blood culture. The primary outcome was the rate of blood culture contamination for each antisepsis agent.
  
  
  RESULTS
  In total, 12,904 peripheral blood culture sets were evaluated, of which 735 (5.7%) were positive. There were 98 contaminated cultures, representing 13.3% of all positive cultures. The overall blood culture contamination rate for the study population was 0.76%. Intent-to-treat rates of contaminated blood cultures were not significantly different among the 3 antiseptics ([Formula: see text]), yielding 0.58% with PI (95% confidence interval [CI], 0.38%-0.86%), 0.76% with IT (95% CI, 0.52%-1.07%), and 0.93% with CHG (95% CI, 0.67%-1.27%).
  
  
  CONCLUSIONS
  Choice of antiseptic agent does not impact contamination rates when blood cultures are obtained by a phlebotomy team and should, therefore, be based on costs or preference.
  
  
  BACKGROUND
  ClinicalTrials.gov identifier: NCT01216761 .
authors.affiliation: Department of Internal Medicine, Division of Infectious Diseases, University of Michigan Health System, Ann Arbor, Michigan 48109, USA. laraine@med.umich.edu
authors.forename: Laraine L
authors.initials: LL
authors.lastname: Washer
authors.forename: Carol
authors.initials: C
authors.lastname: Chenoweth
authors.forename: Hae-Won
authors.initials: HW
authors.lastname: Kim
authors.forename: Mary A M
authors.initials: MA
authors.lastname: Rogers
authors.forename: Anurag N
authors.initials: AN
authors.lastname: Malani
authors.forename: James
authors.initials: J
authors.lastname: Riddell
authors.forename: Latoya
authors.initials: L
authors.lastname: Kuhn
authors.forename: Bernard
authors.initials: B
authors.lastname: Noeyack
authors.forename: Harry
authors.initials: H
authors.lastname: Neusius
authors.forename: Duane W
authors.initials: DW
authors.lastname: Newton
authors.forename: Sanjay
authors.initials: S
authors.lastname: Saint
authors.forename: Scott A
authors.initials: SA
authors.lastname: Flanders
mesh_terms: D019840:2-Propanol; D000368:Aged; D000891:Anti-Infective Agents, Local; D000985:Antisepsis / Q000379:methods*; D002710:Chlorhexidine / Q000031:analogs & derivatives; D018592:Cross-Over Studies; D005189:False Positive Reactions; D006801:Humans; D007455:Iodine; D016013:Likelihood Functions; D016015:Logistic Models; D008875:Middle Aged; D018962:Phlebotomy / Q000379:methods*; D011206:Povidone-Iodine; D011446:Prospective Studies; D016037:Single-Blind Method; D012867:Skin / Q000382:microbiology*
chemical_list: D000891:Anti-Infective Agents, Local; D011206:Povidone-Iodine; D007455:Iodine; C010882:chlorhexidine gluconate; D019840:2-Propanol; D002710:Chlorhexidine